Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Nov 2023 for Invitae Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David Sholehvar: trading record in brief
This profile gathers the share dealings of David Sholehvar across 2 companies, led by Neogenomics Inc and Invitae Corp. Over a trading history stretching from 1 April 2022 to 13 November 2023, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 14 November 2023 came the latest disclosure, a share grant in Invitae Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Sholehvar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
850,000 shares0Common StockSEC:0000950170-23-063939:0
12,352 shares0Common StockSEC:0001077183-22-000128:0
30,864 shares0Common StockSEC:0001077183-22-000055:0
3 of 3 declarations
